Factors influencing the stability of labelled microbial materials in soils

The effect of freshly added substrate on carbon turnover of a microbial population and the priming action on stabilized soil organic constituents were investigated in the laboratory. ¹³C-labelled glucose. NH₄NO₃, or both were added to samples of a Brown Chernozemic soil which had been initially amended with ¹⁴C-glucose and incubated 2 months under field conditions. At the end of 14 days laboratory incubation. 39 per cent and 33 per cent of the ¹³C had been respired as CO₂ from the glucose and glucose plus NH₄NO₃ treatments, respectively. These two treatments resulted in a marked priming of native ¹²C during the second and third days of incubation and a second priming peak during the fifth day. In contrast, there was only a small priming action of the ¹⁴C-labelled materials. Addition of NH₄NO₃ by itself had no effect on the amount of ¹²C or ¹²C respired.Appreciable amounts of ¹⁴C were mineralized following treatments known to partially sterilize soil. Freezing and thawing was more effective than wetting and drying, but less effective than CHCl₃ vapour in releasing stabilized ¹⁴C materials. The amount of labelled-¹⁴C mineralized during incubation after treatment with chloroform vapour was greater than could he accounted for by the decrease in soil biomass.     

A pleiotropic effect of a mutant haemoglobin type in chickens

The growth rate, viability, and reproductive parameters of a mutant haemoglobin type in chickens were compared with that of normal and heterozygous types. There were no significant differences in the parameters of growth rate, adult body weight or the reproductive parameters of egg weight, fertility, percentage hatch‐ability or sexual maturity. Percentage egg production was significantly depressed in the mutant type compared with normal or heterozygote.     

Preliminary study of ovarian activity in fillies treated with a GnRH vaccine

Objective To investigate the effects of two doses (200 and 400 mg) of a water-soluble gonadotrophin-releasing hormone vaccine on the ovarian activity of 2-year-old fillies.
Design A controlled vaccination dose rate experiment.
Animals Six 2-year-old Australian Stock Horse fillies were randomly allocated to three treatment groups: unvaccinated controls, those receiving 200 mg of the vaccine and those receiving 400 mg of the vaccine.
Results Ovarian activity of the treated fillies was suppressed at the peak of the breeding season while that of the untreated controls continued normally. The control fillies displayed oestrous activity and behaviour. Suppression of ovarian activity occurred for 25 and 30 weeks in the 200 and 400 mg groups, respectively. These differences were not significant. Ovarian activity ceased 2 to 3 weeks after primary vaccination. Antibody titres were low (330) until after the booster immunisation when they rapidly peaked at 22,000 and 28,000 in the 200 mg and 400 mg groups, respectively. Plasma progesterone concentrations of the treated fillies remained below 3.18 nmol/L while GnRH was suppressed. The vaccine had no significant effect on plasma androstenedione concentrations. Recovery from the effect of the vaccine was associated with development of ovarian follicles, normal oestrous behaviour and ovulation. Three of the four treated fillies and one of the controls conceived during the next breeding season and foaled normally. All the treated fillies conceived and produced normal foals in the following two breeding seasons.
Conclusion Both dose rates suppressed ovarian function and prevented oestrous behaviour. These effects were reversible and the subsequent fertility of the vaccinated fillies was normal.     

Alimentary lymphosarcoma in a 4-year-old Labrador retriever

Lymphosarcoma, a common canine hematopoietic neoplasm, occurs in multicentric, alimentary, mediastinal, and extranodal forms. Alimentary lymphoma accounts for approximately 5% of cases and is less easily diagnosed than the more common multicentric form. Chemotherapy is often effective, but recent therapeutic advances hold great promise for success in treating canine lymphoma. A 4-year-old, black Labrador retriever was presented (day 1) with a 2-day history of vomiting, polyuria/polydipsia, lethargy, and anorexia. The heart and respiratory rates were within normal limits, and the rectal temperature was 38.9 degrees C. Abdominal splinting was noted on palpation, which elicited urination. No obvious additional abnormalities were detected.     

Responses to delayed estrus after weaning in sows using oral progestagen treatment

Oral progestagen treatment extends the weaning-to-estrus interval (WEI) in weaned sows. Particularly in lower parity sows, this allows recovery from lactational catabolism and improves sow productivity. However, the optimal duration of progestagen treatment in contemporary dam-line sows is unclear. Therefore, sows (n = 749) weaned over consecutive 3-wk periods in June and July and classified as parity 2 and 3 (P2-3); 4, 5, and 6 (P4-6); or parity 7 or higher (P7+) were organized into 2 breeding groups using 1 of 3 strategies: 1) oral progestagen for 2 d before and 12 d after weaning (M14; n = 249); 2) oral progestagen for 2 d before and 5 d after weaning (M7; n = 250); or 3) no progestagen treatment (M0; n = 250). Progestagen (altrenogest) was administered directly into the sow's mouth at a dosage of 6.8 mL (15 mg of altrenogest) daily. Sows were bred using artificial insemination at first detection of estrus after weaning (M0) or altrenogest withdrawal, and every 24 h thereafter, until they no longer exhibited the standing reflex. The WEI for M0 sows was 5.1 +/- 0.1 d. Estrus was recorded sooner (P < 0.001) after withdrawing treatment in M14 than in M7 sows (6.9 +/- 0.1 vs. 7.4 +/- 0.1 d, respectively). More (P < 0.001) M14 sows (88.6 +/- 2.5%) were bred within 10 d of altrenogest withdrawal than M7 (72.8 +/- 2.8%) sows, or within 10 d of weaning in M0 sows (78.8 +/- 2.6%). Reproductive tracts were recovered after slaughter at d 30 or 50 of gestation. For P2-3 sows, ovulation rate (least squares mean +/- 95% confidence interval) in M7 (23.1 +/- 1.0) was greater (P < 0.001) than in M14 (20.7 +/- 1.0) or M0 (19.7 +/- 1.0) sows; no differences were detected in P4-6 and P7+ sows. At d 30, M7 and M14 sows had more (P < 0.01) embryos (16.4 +/- 0.6 and 15.8 +/- 0.4, respectively) than M0 (13.9 +/- 0.5) sows. At d 50 of gestation, number of fetuses in M14 sows (13.6 +/- 0.4) was greater (P < 0.001) than in M0 (11.8 +/- 0.4) and M7 (12.2 +/- 0.3) sows. Use of oral progestagen to delay the return to postweaning estrus for greater than 18 d appears to have potential for improving weaned sow productivity. Given the incidence of high ovulation rates and associated evidence of intrauterine crowding of embryos around d 30 of gestation, the changing dynamics of prenatal loss resulting from longer periods of progestagen treatment may represent an additional production advantage.     

Efficacy of a topically applied spot-on formulation of a novel insecticide, metaflumizone, applied to cats against a flea strain (KS1) with documented reduced susceptibility to various insecticides

A spot-on metaflumizone formulation was evaluated in adult domestic short hair cats to determine its adultidical efficacy against a flea strain that has reduced susceptibility to a number of insecticides. Eight cats served as non-treated controls, eight cats were treated with a metaflumizone formulation at 0.2 ml/kg (40 mg metaflumizone/kg) and eight cats were treated with fipronil 10% w/v-(s)-methoprene 12%w/v at 0.075 ml/kg (7.5-7.7 mg fipronil/kg:9.0-9.2 mg (s)-methoprene/kg). On days -1, 7, 14, 21, 28, 35, and 42 each cat was infested with approximately 100 unfed KS1 cat fleas, Ctenocephalides felis. At approximately 48 h after treatment or infestation, each cat was combed to remove and count live fleas. Treatment with metaflumizone provided > or = 99.3% efficacy for 3 weeks post-treatment and then 97.4, 91.4 and 86.2% efficacy at 4, 5 and 6 weeks post-treatment, respectively. Fipronil-(s)-methoprene provided 99.6% efficacy at 1 week post-treatment and then 97.6, 96.4, 71.3, 22.0 and 13.1% efficacy at weeks 2, 3, 4, 5 and 6, respectively. The reductions in flea numbers were significantly greater for the metaflumizone treatment than for fipronil-(s)-methoprene from 3 to 6 weeks after treatment.